Microarrays as a diagnostic tool in prenatal screening strategies: Ethical reflection

Human Genetics

Volumn 133, Issue 2, 2014, Pages 163-172

  De Jong, Antina ^a,c   Dondorp, Wybo J ^a,b   Macville, Merryn V E ^b   De Die Smulders, Christine E M ^a,d   Van Lith, Jan M M ^e   De Wert, Guido M W R ^a,b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c CSG Centre for Society and the Life Sciences   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DECISION MAKING; FETUS DISEASE; GENETIC COUNSELING; GENOME; HUMAN; MICROARRAY ANALYSIS; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL;

CHROMOSOME ABERRATIONS; DECISION MAKING; FEMALE; GENETIC TESTING; HUMANS; MICROARRAY ANALYSIS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84893188552     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-013-1365-5     Document Type: Article

References (60)

1. ACOG (2009) Array comparative genomic hybridization in prenatal diagnosis. Committee Opinion Number 446. Obstet Gynecol 114:5
2. Alesi V, Bertoli M, Sinibaldi L, Novelli A (2013) The clinical utility and indications of chromosomal microarray analysis in prenatal diagnosis. BJOG 120:119-120
3. American College of Medical Quality (2011) Professional and ethical policies of the American College of Medical Quality, Policy 3. Standard of care; Policy 8. Definition and application of medical necessity. http://www.acmq.org/ policies/policy8.pdf
4. Armengol L, Nevado J, Serra-Juhé C, Plaja A, Mediano C, García-Santiago F et al (2012) Clinical utility of chromosomal microarray analysis in invasive prenatal diagnosis. Hum Genet 131:513-523
5. Bassem A, Bejjani B, Shaffer L (2006) Targeted array CGH. J Mol Diagn 8:537-539
6. Beauchamp TL, Childress JF (2009) Principles of biomedical ethics. Oxford University Press Inc, Oxford
7. Bejjani B, Shaffer L (2006) Application of array-based comparative genomic hybridization to clinical diagnostics. Mol Diagn 8:528-533
8. Bernhardt B, Soucier D, Hanson K, Savage M, Jackson L, Wapner R (2013) Women's experiences receiving abnormal prenatal chromosomal microarray testing results. Genet Med 15:139-145
9. Cavalli P, Cavallari U, Novelli A (2012) Array CGH in routine prenatal diagnosis practice. Prenat Diagn 32:708-709
10. Choy K, Setlur S, Lee C, Lau T (2010) The impact of human copy number variation on a new era of genetic testing. BJOG 117:391-398
11. Coppinger J, Alliman S, Lamb A, Torchia B, Bejjani B, Shaffer L (2009) Whole-genome microarray analysis in prenatal specimens identifies clinically significant chromosome alterations without increase in results of unclear significance compared to targeted microarray. Prenat Diagn 29:1156-1166
12. D'Amours G, Kibar Z, Mathonnet G, Fetni R, Tihy F, Désilets V, Nizard S, Michaud JL, Lemyre E (2012) Whole-genome array CGH identifies pathogenic copy number variations in fetuses with major malformations and a normal karyotype. Clin Genet 81:128-141
13. de Jong A, Dondorp W, Frints S, de Die-Smulders C, de Wert G (2011a) Advances in prenatal screening: the ethical dimension. Nat Rev Genet 12:657-663
14. de Jong A, Dondorp W, Timmermans D, van Lith J, de Wert G (2011b) Rapid aneuploidy detection or karyotyping? Ethical reflection. Eur J Hum Genet 19:1020-1025
15. de Wit M, Srebniak M, Govaerts L, Van Opstal D, Galjaard R, Go A (2013) The additional value of prenatal genomic array testing in fetuses with (isolated) structural ultrasound abnormalities and a normal karyotype: a systematic review of the literature. Ultrasound Obstet Gynecol. doi: 101002/uog125752013
16. Dondorp W, Sikkema-Raddatz B, de Die-Smulders C, de Wert G (2012) Arrays in postnatal and prenatal diagnosis: an exploration of the ethics of consent. Hum Mutat 33:916-922
17. Edelmann L, Hirschhorn K (2009) Clinical utility of array CGH for the detection of chromosomal imbalances associated with mental retardation and multiple congenital anomalies. N Y Acad Sci 1151:157-166
18. Emanuel E, Emanuel L (1992) Four models of the physician-patient relationship. JAMA 267:2221-2226
19. Faas B, van der Burgt I, Kooper A, Pfundt R, Hehir-Kwa J, Smits A et al (2010) Identification of clinically significant, submicroscopic chromosome alterations and UPD in fetuses with ultrasound anomalies using genome-wide 250 k SNP array analysis. J Med Genet 47:586-594
20. Faas BHW, Cirigliano V, Bui T-H (2011) Rapid methods for targeted prenatal diagnosis of common chromosome aneuploidies. Sem Fet Neonat Med 16:81-87
21. Fiorentino F, Napoletano S, Caiazzo F, Sessa M, Bono S, Spizzichino L, Gordon A, Nuccitelli A, Rizzo G, Baldi M (2013) Chromosomal microarray analysis as a first-line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities. Eur J Hum Genet 21:725-730
22. Fruhman G, van den Veyver I (2010) Applications of array comparative genomic hybridization in obstetrics. Obstet Gynecol Clin North Am 37:71-85
23. Ganesamoorthy D, Bruno DL, McGillivray G, Norris F, White SM, Adroub S, Amor DJ, Yeung A, Oertel R, Pertile MD, Ngo C, Arvaj AR, Walker S, Charan P, Palma-Dias R, Woodrow N, Slater HR (2013) Meeting the challenge of interpreting high-resolution single nucleotide polymorphism array data in prenatal diagnosis: does increased diagnostic power outweigh the dilemma of rare variants? BJOG 120:594-606
24. Health Council of the Netherlands (2008) Screening: between hope and hype. Publication no. 2008/05
25. Hillman S, Pretlove S, Coomarasamy A, McMullan D, Davison E, Maher E et al (2011) Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 37:6-14
26. Hillman S, McMullan D, Maher E, Kilby M (2012) Clinical utility of array comparative genomic hybridisation for prenatal diagnosis: a cohort study of 3171 pregnancies. BJOG 119:1281-1282
27. Javaher P, Schmidtke J (2010) Clinical validity and utility of genetic testing in heritable disorders. In: Kristofferson U, Schmidtke J, Cassiman J-J (eds) Quality issues in clinical genetic services. Springer, Dordrecht, pp 147-156
28. Kitzman JO, Snyder MW, Ventura M, Lewis AP, Qiu R, Simmons LE et al (2012) Noninvasive whole-genome sequencing of a human fetus. Sci Transl Med 4:137ra176
29. Kleeman L, Bianchi D, Shaffer L, Rorem E, Cowan J, Craigo S et al (2009) Use of array comparative genomic hybridization for prenatal diagnosis of fetuses with sonographic anomalies and normal metaphase karyotype. Prenat Diagn 29:1213-1217
30. Le Caignec C, Boceno M, Saugier-Veber P, Jacquemont S, Joubert M, David A et al (2005) Detection of genomic imbalances by array based comparative genomic hybridisation in fetuses with multiple malformations. J Med Genet 42:121-128
31. Leung T, Vogel I, Lau T, Hyett J, Petersen O et al (2011) Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype. Ultrasound Obstet Gynecol 38:314-319
32. Maya I, Davidov B, Gershovitz L, Zalzstein Y, Taub E, Coppinger J et al (2010) Diagnostic utility of array-based comparative genomic hybridization (aCGH) in a prenatal setting. Prenat Diagn 30:1131-1137
33. McGillivray G, Rosenfield J, McKinlay Gardner R, Dillam L (2012) Genetic counselling and ethical issues with chromosome microarray analysis in prenatal testing. Prenat Diagn 32:389-395
34. Miller D, Adam M, Aradhya S, Biesecker L, Brothman A, Carter N et al (2010) Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 14:749-764
35. Novelli A, Grati F, Ballarati L, Bernardini L, Bizzoco D, Camurri L et al (2012) Microarray application in prenatal diagnosis: a position statement from the cytogenetics working group of the Italian Society of Human Genetics (SIGU). Ultrasound Obstet Gynecol 39:384-388
36. Park J, Woo J, Shim S, Yang S, Choi Y, Yang K et al (2010) Application of a target array comparative genomic hybridization to prenatal diagnosis. BMC Med Genet 11:102
37. Park S-J, Jung E, Ryu R-S, Kang H, Ko J-M, Kim H et al (2011) Clinical implementation of whole-genome array CGH as a first-tier test in 5080 pre and postnatal cases. Mol Cytogenet 4:12
38. Rehm H (2013) Disease-targeted sequencing: a cornerstone in the clinic. Nat Rev Genet 14:295-300
39. Reiff M, Ross K, Mulchandani S, Propert K, Pyeritz R, Spinner N et al (2012) Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and families. Clin Genet 83:23-30
40. Salomon L, Alfirevic Z, Berghella V, Bilardo C, Hernandez-Andrade E, Johnsen S et al (2011) Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol 37:116-126
41. Savage M, Mourad M, Wapner R (2011) Evolving applications of microarray analysis in prenatal diagnosis. Current Op Obstet Gynecol 23:103-108
42. Scott F, Murphy K, Carey L, Greville W, Mansfield N, Barahona P et al (2013) Prenatal diagnosis using combined quantitative fluorescent polymerase chain reaction and array comparative genomic hybridization analysis as a first-line test: results from over 1000 consecutive cases. Ultrasound Obstet Gynecol 41:500-507
43. Shaffer L, Kashork C, Saleki R, Rorem E, Sundin K, Ballif B et al (2006) Targeted genomic microarray analysis for identification of chromosome abnormalities in 1500 consecutive clinical cases. J Pediatrics 149:98-102
44. Shaffer LG, Coppinger J, Alliman S, Torchia BA, Theisen A, Ballif BC et al (2008) Comparison of microarray-based detection rates for cytogenetic abnormalities in prenatal and neonatal specimens. Prenat Diagn 28:789-795
45. Shaffer L, Dabell M, Fisher A, Coppinger J, Bandholz A, Ellison J et al (2012) Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies. Prenat Diagn 32:976-985
46. Sonek J (2007) First trimester ultrasonography in screening and detection of fetal anomalies. Am J Med Genet C Semin Med Genet 145C(1):45-61
47. Srebniak M, Boter M, Oudesluijs G, Cohen-Overbeek T, Govaerts L, Diderich K et al (2012) Genomic SNP array as a gold standard for prenatal diagnosis of foetal ultrasound abnormalities. Mol Cytogenet 5:14
48. Srinivasan A, Bianchi D, Huang H, Sehnert A, Rava R (2013) Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 92:167-176
49. Stankiewicz P, Beaudet A (2007) Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. Curr Opin Genet Dev 17:182-192
50. Tyreman M, Abbott K, Willatt L, Nash R, Lees C, Whittaker J et al (2009) High resolution array analysis: diagnosing pregnancies with abnormal ultrasound findings. J Med Genet 46:531-541
51. UK NSC (2007) National Screening Committee and NHS antenatal and newborn screening programmes. Antenatal screening - working standards for down's syndrome screening 2007. National down's syndrome screening programme for England
52. Van den Veyver I, Patel A, Shaw C, Pursley A, Kang S, Simovich M et al (2009) Clinical use of array comparative genomic hybridization (aCGH) for prenatal diagnosis in 300 cases. Prenat Diagn 29:29-39
53. Veltman J, de Vries B (2006) Diagnostic genome profiling: unbiased whole genome or targeted analysis? J Mol Diagn 8:534-537
54. Vermeesch JR, Fiegler H, de Leeuw N, Szuhai K, Schoumans J, Ciccone R et al (2007) Guidelines for molecular karyotyping in constitutional genetic diagnosis. Eur J Hum Genet 15:1105-1114
55. Vetro A, Bouman K, Hastings R, McMullan D, Vermeesch JR, Miller K et al (2012) The introduction of arrays in prenatal diagnosis: a special challenge. Hum Mutat 33:923-929
56. Wapner R, Driscoll D, Simpson J (2012a) Integration of microarray technology into prenatal diagnosis: counselling issues generated during the NICHD clinical trial. Prenat Diagn 32:396-400
57. Wapner R, Martin C, Levy B, Ballif B, Eng C, Zachary J et al (2012b) Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 367:2175-2184
58. Wilfond B, Nolan K (1993) National policy development for the clinical application of genetic diagnostic technologies. Lessons from cystic fibrosis. JAMA 270:2948-2954
59. Wilson J, Jungner G (1968) Principles and practice of screening for disease. World Health Organisation, Geneve
60. Zuffardi O, Vetro A, Brady P, Vermeesch J (2011) Array technology in prenatal diagnosis. Semin Fetal Neonatal Med 16:94-98